RECRUITING

Regulation of Inflammatory Genes in Psoriasis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.

Official Title

Regulation of Inflammatory Genes in Psoriasis

Quick Facts

Study Start:2014-04-22
Study Completion:2027-04-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03125655

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinical diagnosis of psoriasis
  2. * Must be age 19 or older.
  3. * Must be Fitzpatrick skin type I, II, III, IV, V, VI.
  1. * Subjects who do not have photosensitive disease and are not on photosensitizing medications.
  2. * Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy).
  3. * Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants.
  4. * Subjects who are pregnant.

Contacts and Locations

Study Locations (Sites)

The Kirklin Clinic
Birmingham, Alabama, 35294
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-04-22
Study Completion Date2027-04-28

Study Record Updates

Study Start Date2014-04-22
Study Completion Date2027-04-28

Terms related to this study

Keywords Provided by Researchers

  • cytokines

Additional Relevant MeSH Terms

  • Psoriasis
  • Inflammation